+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of induction alg malg on the outcome of steroid resistant rejection treatment with okt3 in renal transplant patients



The effect of induction alg malg on the outcome of steroid resistant rejection treatment with okt3 in renal transplant patients



Transplantation Proceedings 23(1 BOOK 2): 1039-1040




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033776046

Download citation: RISBibTeXText


Related references

The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients. Transplantation Proceedings 23(1 Pt 2): 1039-1040, 1991

Effect of OKT3 in steroid-resistant renal transplant rejection. Transplantation 59(3): 347-352, 1995

Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Transplantation Proceedings 28(3): 1354-1355, 1996

Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. Transplantation Proceedings 29(7): 2955-2957, 1997

FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Transplantation Proceedings 28(6): 3166-3168, 1996

FK 506 is as effective as OKT3 for initial treatment for steroid resistant rejection in liver transplant patients. Hepatology 22(4 Part 2): 143A, 1995

Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center. Transplantation Proceedings 31(7): 2870-2871, 1999

Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis. American Journal of Kidney Diseases 21(2): 196-201, 1993

Induction vs non induction therapy-OKT3/MALG, ATG in renal transplantation outcome and cost analysis. Journal of the American Society of Nephrology 6(3): 1070, 1995

Renal transplantation induction therapy OKT3 vs MALG Outcome, cost. Nephrology Dialysis Transplantation 10(6): 1069, 1995

Severe thrombocytopenia with OKT3 use for steroid-resistant rejection in a cadaveric renal transplant recipient. Nephrology Dialysis Transplantation 11(11): 2378, 1996

One year outcome of renal allograft recipients treated with okt3 for steroid resistant rejection. Clinical & Investigative Medicine 15(4 Suppl.): A150, 1992

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients. Journal of Pediatric Gastroenterology and Nutrition 14(1): 86-91, 1992

OKT3 monoclonal antibody treatment of steroid-resistant liver transplant rejection. Current Therapeutic Research. 55(4): 382-395, 1994

Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection. Transplant International 7(4): 278-283, 1994